<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01655121</url>
  </required_header>
  <id_info>
    <org_study_id>GAS-501-11/12-1</org_study_id>
    <nct_id>NCT01655121</nct_id>
  </id_info>
  <brief_title>Effect of High-protein High-fiber Diet in Patients With Autoimmune Hepatitis</brief_title>
  <official_title>Effect of a High-protein High-fiber Diet and Nutritional Status, Serum Ammonia Concentration and Plasma Cytokines in Patients With Autoimmune Hepatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autoimmune hepatitis is a chronic disease of the liver caused by an alteration of the immune&#xD;
      response that attacks the body's own hepatocytes, progressively, leading to cirrhosis and&#xD;
      liver failure.&#xD;
&#xD;
      There are few studies on dietary management in hepatitis and most of theme have focused on&#xD;
      micronutrients specifically vitamin D to prevent osteoporosis, and decreased symptoms of&#xD;
      other diseases associated, but few recommendations have been made regarding a complete&#xD;
      dietary approach. Fiber has been proven to increase the excretion of nitrogen products and&#xD;
      consequently reduce its blood levels and an adequate protein intake (1.2g/kg) has shown to&#xD;
      decrease endogenous catabolism in cirrhotics patients.&#xD;
&#xD;
      The implementation of a high protein high fiber nutrition plan and improves nutritional&#xD;
      status of patients with autoimmune cirrhosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each participant will receive a high protein (1.2g/kg/day) and high fiber (30g/day) dietary&#xD;
      plan. The monitoring of adherence to the diet will be once a month for the duration of the&#xD;
      study period.&#xD;
&#xD;
      There will be an nutritional assessment by anthropometric techniques: arm circumference,&#xD;
      triceps skinfold, weight, height and body mass index as parameters of malnutrition by taking&#xD;
      the standard for cirrhotic patients. Body composition was measured by bioelectric impedance&#xD;
      to obtain fat mass, lean and total fluid content.&#xD;
&#xD;
      The presence of minimal hepatic encephalopathy will be assessed by PHES and CFF and applied&#xD;
      three times during the study and the quality of life questionnaire SF-36 CLDQ and will be&#xD;
      held in direct interview at the first visit and at study end.&#xD;
&#xD;
      Were also measured serum concentrations of ammonium, TNF-alpha, IL-1, IL-6, IL-10, renin,&#xD;
      angiotensin and aldosterone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nutritional Status</measure>
    <time_frame>Participants will be assessed for six months</time_frame>
    <description>Measured with the following parameters:body weight and height (to calculate BMI), triceps skinfold and mid-arm circumference (to calculated mid-arm muscle circumference, fat mass, fat free mass total, intracellular and extracellular body water obtained by bioelectrical impedance analysis and individual vectors obtained by bioelectrical impedance vector analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minimal hepatic encephalopathy</measure>
    <time_frame>Participants will be assessed for six months</time_frame>
    <description>Assessed by psychometric Hepatic Encephalopathy (PHES) and Critical Flicker Frequency (CFF), at visit 0 months and 6 months visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Participants will be assessed for six months</time_frame>
    <description>Assessed by CLDQ and SF-36 questionnaires, at visit 0 months and 6 months visit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Autoimmune Hepatitis</condition>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Autoimmune hepatitis (Non-cirrhotic)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A personalized high protein high fiber dietary plan will be provided to each participant from both groups. Each participant will receive nutritional counseling once a month during six months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Autoimmune hepatitis (Cirrhotic)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A personalized high protein high fiber dietary plan will be provided to each participant from both groups. Each participant will receive nutritional counseling once a month during six months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High protein high fiber diet</intervention_name>
    <description>A personalized high protein high fiber dietary plan will be provided to each participant from both groups. Each participant will receive nutritional counseling once a month during six months.&#xD;
Each participant will receive nutritional counseling once month during six months.</description>
    <arm_group_label>Autoimmune hepatitis (Cirrhotic)</arm_group_label>
    <arm_group_label>Autoimmune hepatitis (Non-cirrhotic)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Autoimmune hepatitis (Non cirrhotic)&#xD;
&#xD;
          -  Diagnose of Autoimmune hepatitis&#xD;
&#xD;
          -  Presence of antinuclear antibody (ANA, SMA)&#xD;
&#xD;
          -  Biochemical evidence, based on elevation of transaminases&#xD;
&#xD;
          -  Biopsy compatible with Autoimmune hepatitis&#xD;
&#xD;
          -  Ambulatory patients&#xD;
&#xD;
        Autoimmune hepatitis (Cirrhotic)&#xD;
&#xD;
          -  Presence of antinuclear antibody (ANA, SMA)&#xD;
&#xD;
          -  Biochemical evidence, based on elevation of transaminases&#xD;
&#xD;
          -  Biopsy compatible with autoimmune cirrhosis&#xD;
&#xD;
          -  Hepatic cirrhosis by USD&#xD;
&#xD;
          -  Ambulatory patients&#xD;
&#xD;
          -  Diagnose of Autoimmune cirrhosis by two or more of the following criteria:&#xD;
&#xD;
          -  Albumin &lt;3.4g/dl&#xD;
&#xD;
          -  INR&gt;1.2&#xD;
&#xD;
          -  Total bilirubin &gt;2mg/dl&#xD;
&#xD;
          -  Presence of esophageal varices by endoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hospitalized patients&#xD;
&#xD;
          -  Overlapping syndrome with predominant primary biliary cirrhosis&#xD;
&#xD;
          -  Chronic renal failure&#xD;
&#xD;
          -  Hepatocellular carcinoma&#xD;
&#xD;
          -  Neuropsychiatric disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aldo Torre Delgadillo, M.D. M.Sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>INCMNSZ</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</name>
      <address>
        <city>Mexico City</city>
        <state>D.f.</state>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>July 12, 2012</study_first_submitted>
  <study_first_submitted_qc>July 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2012</study_first_posted>
  <last_update_submitted>August 18, 2014</last_update_submitted>
  <last_update_submitted_qc>August 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 20, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>ALDO TORRE DELGADILLO</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis, Autoimmune</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

